Row rect Shape Decorative svg added to top
Sept26

Join biotech founders, pharma executives and healthcare investors for a magical evening of celebration and hope for families of children with ataxia-telangiectasia (A-T).

Co-hosts:

David Altshuler, MD, PhD Executive Vice President & (former) Chief Scientific Officer, Vertex

Dame Kate Bingham Managing Partner, SV Health Investors

Jane Grogan, PhD Executive Vice President, Head of Research, Biogen

Avak Kahvejian, PhD General Partner, Flagship Pioneering

Peter Kolchinsky, PhD Co-founder & Managing Partner, RA Capital

Eirene Kontopoulos, PhD Biotech Analyst & Portfolio Manager, Fidelity Investments

Robert Langer, ScD Institute Professor, Massachusetts Institute of Technology

David Liu, PhD Co-founder, Beam, Prime, Editas, nChroma; Professor, Broad Institute, Harvard, and HHMI

Brad Margus Founder & Board Chair, A-T Children's Project; A-T Dad

Kush Parmar, MD, PhD Managing Partner, 5AM Ventures

Andy Plump, MD, PhD President of Research & Development, Takeda Pharmaceuticals

David Schenkein, MD General Partner & Co-lead of Life Sciences, GV (Google Ventures)

Jim Tananbaum, MD, MBA Founder & CEO, Foresite Capital

Jason Uslaner, PhD Vice President & Head of Neuroscience, Merck

Anne Wojcicki Co-founder & CEO, 23andMe Research Institute

Tables & Tickets

Electronic transfer funds encouraged. Click on benefits for payment information.

Questions?

Please contact Jennifer Thornton, Executive Director
jennifer@atcp.org
Cell: 561-306-2826

B20

See photos, sponsors and more from the IlluminATion Ball that was held in 2024.